Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database:
Rebecca T Levinson1, Cinara Paul1, Andreas D Meid2
1Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
JMIR Cardio
|July 23, 2024
Summary
Machine learning accurately predicts heart failure (HF) readmissions using health insurance data. Novel factors like rurality and specific comorbidities increase readmission risk, aiding outpatient management.
Area of Science:
- Health Informatics
- Machine Learning in Healthcare
- Cardiology Research
Background:
- Heart failure (HF) patients are frequently readmitted, often for noncardiovascular reasons.
- Understanding outpatient HF management is key to reducing readmissions.
- Machine learning (ML) on health insurance data offers insights into large, representative populations.
Purpose of the Study:
- To assess ML's ability to predict 1-year all-cause and HF-specific readmissions.
- To identify key predictors of readmission in patients with HF.
- To utilize outpatient statutory health insurance (SHI) data for predictive modeling.
Main Methods:
- Utilized SHI data (AOK Baden-Württemberg) from 2012-2018 for individuals with HF.
- Trained and applied ML algorithms (Random Forest, Elastic Net, etc.) to predict readmissions.
- Included diagnosis codes, drug exposures, demographics, rurality, and disease management program participation as predictors.
Main Results:
- The Random Forest model achieved the highest predictive accuracy (C-statistic 0.68 for all-cause, 0.69 for HF-specific).
- Key predictors for all-cause readmission included pantoprazole use, COPD, atherosclerosis, sex, rurality, and participation in diabetes/CHD management programs.
- HF-specific readmission was strongly associated with HF comorbidities.
Conclusions:
- Identified known HF comorbidities and novel predictors for readmission risk.
- Disease management programs can help target high-risk HF patients with comorbidities.
- Rural location and factors beyond comorbidities significantly influence HF readmission risk, informing outpatient care strategies.
Keywords:
all causecardiaccardiologyheartheart failurehospitalizationinsurancemachine learningpredictpredictionpredictionspredictivepredictorpredictorsreadmissionstatutory health insuranceMore Related Videos
Related Concept Videos
Heart Failure Drugs: β-Blockers
333
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
333
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
Heart Failure Drugs: Inotropic Agents
559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559


